Holen Sie sich die Stockscreener-App
21.60
1.46%
-0.32
Finanzdaten der Inhibrx Biosciences Inc-Aktie (INBX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
1.634 | 0.119 | 0.03 | 0.017 |
Operating Expenses
|
17.90%
73.83
|
89.92 | 45.95 | 41.37 | 43.78 |
| Operating Income/Loss |
16.38%
-73.83
|
-88.29 | -45.83 | -41.34 | -43.77 |
| Nonoperating Income/Loss |
32.56%
-4.885
|
-3.685 | -5.96 | -5.708 | -5.15 |
| Income/Loss From Continuing Operations Before Tax |
14.42%
-78.71
|
-91.97 | -51.79 | -47.05 | -48.92 |
| Income Tax Expense/Benefit |
100.00%
-
|
-0.004 | 0.002 | 0.005 | - |
| Income/Loss From Continuing Operations After Tax |
14.42%
-78.71
|
-91.97 | -51.79 | -47.05 | -48.92 |
|
Net Income/Loss
|
15.91%
-78.71
|
-93.60 | -51.79 | -47.05 | -48.92 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,244%
54.55
|
2.327 | 47.15 | 43.64 | 43.58 |
| Diluted Average Shares |
2,244%
54.55
|
2.327 | 47.15 | 43.64 | 43.58 |
| Basic Earnings Per Share |
20.88%
-1.44
|
-1.82 | -1.10 | -1.08 | -1.12 |
| Diluted Earnings Per Share |
20.88%
-1.44
|
-1.82 | -1.10 | -1.08 | -1.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):